Recent news about Blis Technologies.
Meet us at Vitafoods Asia 2024 where we will be presenting our latest probiotic innovations and clinical research.
Otitis media, a term that may sound unfamiliar to many, refers to a common condition that affects the middle ear. This inflammation can occur in people of all ages but is particularly prevalent in children.
One of the most common and painful side effects of cancer treatment is mouth sores, medical known as oral mucositis, affecting a significant percentage of patients undergoing chemotherapy and radiotherapy. Recent studies have highlighted the potential of BLIS K12™ in providing much-needed relief for this condition.
We’re partnering with the IPA World Congress + Probiota Americas this June. Join us in Salt Lake City to dive into the world of microbiome science and business.
In our latest whitepaper, a recent study shows that BLIS K12™ stimulates the production of antibodies specific to SARS CoV-2 virus in people that have been vaccinated for COVID-19 and led to accelerated viral clearance.
Otitis media, a term that may sound unfamiliar to many, refers to a common condition that affects the middle ear. This inflammation can occur in people of all ages but is particularly prevalent in children.